These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 2867827
1. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis]. Vavrejnová V, Felt V, Nedvídková J. Cas Lek Cesk; 1985 Oct 25; 124(43):1320-3. PubMed ID: 2867827 [No Abstract] [Full Text] [Related]
2. [Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)]. Nedvídková J, Cenková V, Felt V. Cas Lek Cesk; 1980 Jul 11; 119(27-28):749-51. PubMed ID: 6107177 [No Abstract] [Full Text] [Related]
3. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)]. Felt V, Nedvídková J. Cas Lek Cesk; 1982 Mar 05; 121(9):266-8. PubMed ID: 6121628 [No Abstract] [Full Text] [Related]
4. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol. Planz G, Haass H, Lamberts B. Int J Clin Pharmacol Ther Toxicol; 1982 Oct 05; 20(10):469-73. PubMed ID: 6128312 [Abstract] [Full Text] [Related]
5. Nadolol in thyrotoxicosis. Peden NR, Isles TE, Stevenson IH, Crooks J. Br J Clin Pharmacol; 1982 Jun 05; 13(6):835-40. PubMed ID: 6124267 [Abstract] [Full Text] [Related]
7. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease. Pupita F, Ansuini R, Belogi M, Pupita G, Gaggi S. Int J Clin Pharmacol Res; 1985 Jun 05; 5(6):439-45. PubMed ID: 2869001 [Abstract] [Full Text] [Related]
8. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate]. Weth G, Schneider J, Rodatz H, Haubitz I. Arzneimittelforschung; 1985 Jun 05; 35(11):1711-3. PubMed ID: 2868733 [Abstract] [Full Text] [Related]
10. Effect of beta-blocking agents in hyperthyroidism. Földes J, Bános C, Borvendég J, Gyertyánfy G. Acta Med Acad Sci Hung; 1979 Jun 05; 36(4):375-80. PubMed ID: 45285 [Abstract] [Full Text] [Related]
11. [Trials in pressure regulation with metipranolol eyedrops in special forms of glaucoma in ophthalmologic practice]. Demmler N. Klin Monbl Augenheilkd; 1983 Feb 05; 182(2):153-5. PubMed ID: 6133028 [Abstract] [Full Text] [Related]
12. [Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade]. Horn HG, Neuss H, Schlepper M, Mitrovic V, Stämmler G. Med Klin; 1980 Sep 26; 75(20):721-5. PubMed ID: 6106885 [Abstract] [Full Text] [Related]
17. [Antiglaucomatous effectiveness of beta receptor blockers with special reference to metipranolol]. Noack E. Klin Monbl Augenheilkd; 1986 Jul 26; 189(1):1-3. PubMed ID: 2876128 [Abstract] [Full Text] [Related]
18. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis. Wilkinson R, Burr WA. Am Heart J; 1984 Oct 26; 108(4 Pt 2):1160-7. PubMed ID: 6148879 [Abstract] [Full Text] [Related]
19. [Metipranolol in the prevention of intraocular pressure elevation after cataract extraction]. Schmitz-Valckenberg P. Klin Monbl Augenheilkd; 1983 Feb 26; 182(2):150-2. PubMed ID: 6133027 [Abstract] [Full Text] [Related]
20. [The advantage of hypertension therapy with a once-daily beta-blocker-diuretic combination]. Teufel W, Glocke M. Med Klin; 1981 Aug 28; 76(18):513-5. PubMed ID: 6116170 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]